Watson to Match Patients to Clinical Trials

IBM’s cognitive computer will be individualizing trial plans for cancer patients at the Mayo Clinic.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, CLOCKREADYIBM’s Watson is one busy machine. Already deployed to aid researchers and clinicians at several institutions, the “cognitive computer” is now helping oncologists at the Mayo Clinic in Rochester, Minnesota, to sift through reams of patient records and sort individuals afflicted with cancer into appropriate clinical trials. “In an area like cancer, where time is of the essence, the speed and accuracy that Watson offers will allow us to develop an individualized treatment plan more efficiently so we can deliver exactly the care that the patient needs,” Steven Alberts, chair of medical oncology at Mayo Clinic, said in a statement.

Watson could ease the burden on clinical trial coordinators by matching thousands of patients, each with a unique health history and suite of symptoms, with thousands of experimental protocols that are designed to capture specific individuals. This should benefit not only patients, but the scientists who are running trials, said investigators at the Mayo Clinic. “With shorter times from initiation to completion of trials, our research teams will have the capacity for deeper, more complete investigations,” Nicholas LaRusso, a Mayo Clinic gastroenterologist and the project lead for the Mayo-IBM Watson collaboration, said in the statement. “Coupled with increased accuracy, we will be able to develop, refine and improve new and better techniques in medicine at a higher level.”

The computer, which will become more efficient ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina
Exploring Cellular Organization with Spatial Proteomics

Exploring Cellular Organization with Spatial Proteomics

Abstract illustration of spheres with multiple layers, representing endoderm, ectoderm, and mesoderm derived organoids

Organoid Origins and How to Grow Them

Thermo Fisher Logo

Products

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo
Abstract background with red and blue laser lights

VANTAstar Flexible microplate reader with simplified workflows

BMG LABTECH